Related Experiment Videos
Altered serotonergic and cholinergic synaptic markers in Pick's disease
1Alzheimer's Disease Research Center/Sanders-Brown Center on Aging, Department of Pathology, University of Kentucky Medical Center, Lexington 40536-0230.
Archives of Neurology
|August 1, 1991
Summary
This study examined neurotransmitter markers in Pick's disease brains. Unlike Alzheimer's disease, Pick's disease shows distinct alterations in specific brain regions and neurotransmitter systems.
Area of Science:
- Neuroscience
- Neuropathology
- Neurochemistry
Background:
- Pick's disease is a rare neurodegenerative disorder.
- Understanding its neurochemical underpinnings is crucial for differential diagnosis.
- Previous studies have explored synaptic markers in Alzheimer's disease.
Purpose of the Study:
- To investigate choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) activities.
- To assess serotonin and imipramine binding in brain regions affected by Pick's disease.
- To compare these findings with those reported for Alzheimer's disease.
Main Methods:
- Measurement of ChAT and AChE activities in brain tissue homogenates.
- Radioligand binding assays for serotonin and imipramine.
- Analysis of samples from the hypothalamus, nucleus basalis of Meynert, and frontal/temporal poles.
Main Results:
- Decreased ChAT activity in the hypothalamus and nucleus basalis of Meynert.
- Decreased AChE activity specifically in the nucleus basalis of Meynert.
- Reduced serotonin binding in most examined regions, except the nucleus basalis of Meynert.
- Altered imipramine binding was observed only in the frontal pole.
Conclusions:
- Pick's disease exhibits a unique pattern of synaptic marker alterations.
- These neurochemical differences distinguish Pick's disease from Alzheimer's disease.
- The findings highlight the importance of regional and molecular specificity in neurodegenerative diseases.